Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Morrissey

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|October 23, 2012
The UCSF-FDA TransPortal: a public drug transporter databaseK M Morrissey, C C Wen, S J Johns, et al.
Journal of Chromatography. A|July 26, 2000
Multiple-technique analytical characterization of a mixture containing chemical-weapons simulant from a munitionM D Brickhouse, W R Creasy, B R Williams, et al.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|October 23, 2012
The UCSF-FDA TransPortal: a public drug transporter databaseK M Morrissey, C C Wen, S J Johns, et al.
Journal of Chromatography. A|July 26, 2000
Multiple-technique analytical characterization of a mixture containing chemical-weapons simulant from a munitionM D Brickhouse, W R Creasy, B R Williams, et al.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 1